Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Deeks

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|August 1, 1997
Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between daysS G Deeks, R L Coleman, R White, et al.
AIDS (London, England)|July 9, 1999
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapyS G Deeks, F M Hecht, M Swanson, et al.
Neurology|August 13, 2008
Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot studyJ C Probasco, S S Spudich, J Critchfield, et al.
HIV Medicine|February 26, 2015
Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialM G Law, A Achhra, S G Deeks, et al.
Clinical and Experimental Immunology|July 11, 2012
Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patientsH Lim, L Kane, J B Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapyS S Huang, J D Barbour, S G Deeks, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 5, 2014
Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsP G Stock, B Barin, H Hatano, et al.
Mucosal Immunology|November 10, 2016
Predominance of weakly cytotoxic, T-bet<sup>Low</sup>Eomes<sup>Neg</sup> CD8<sup>+</sup> T-cells in human gastrointestinal mucosa: implications for HIV infectionB E Kiniry, A Ganesh, J W Critchfield, et al.
AIDS (London, England)|June 27, 2001
Cerebrospinal fluid response to structured treatment interruption after virological failureR W Price, E E Paxinos, R M Grant, et al.
The Journal of Infectious Diseases|May 6, 1999
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcomeS G Deeks, N S Hellmann, R M Grant, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|August 1, 1997
Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between daysS G Deeks, R L Coleman, R White, et al.
AIDS (London, England)|July 9, 1999
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapyS G Deeks, F M Hecht, M Swanson, et al.
Neurology|August 13, 2008
Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot studyJ C Probasco, S S Spudich, J Critchfield, et al.
HIV Medicine|February 26, 2015
Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialM G Law, A Achhra, S G Deeks, et al.
Clinical and Experimental Immunology|July 11, 2012
Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patientsH Lim, L Kane, J B Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapyS S Huang, J D Barbour, S G Deeks, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 5, 2014
Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsP G Stock, B Barin, H Hatano, et al.
Mucosal Immunology|November 10, 2016
Predominance of weakly cytotoxic, T-bet<sup>Low</sup>Eomes<sup>Neg</sup> CD8<sup>+</sup> T-cells in human gastrointestinal mucosa: implications for HIV infectionB E Kiniry, A Ganesh, J W Critchfield, et al.
AIDS (London, England)|June 27, 2001
Cerebrospinal fluid response to structured treatment interruption after virological failureR W Price, E E Paxinos, R M Grant, et al.
The Journal of Infectious Diseases|May 6, 1999
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcomeS G Deeks, N S Hellmann, R M Grant, et al.
Pageof 5